Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort
- Conditions
- Winter Sport ResortsOutpatientsLeg Injuries
- Registration Number
- NCT01303523
- Lead Sponsor
- Floralis
- Brief Summary
The purpose of this study is to evaluate the impact of thromboembolic diseases and heparin complications in patients with a lower limb trauma supported by physicians of mountain.
- Detailed Description
The "M2M-thrombose" study is a prospective epidemiological multicenter study involving patients with a lower limb trauma in winter sport resorts. The following initial data required are type of immobilization, treatment with LMWH (Low Molecular Weight Heparin), type of injury (serious or not) and the rolling of the step (normal or abnormal) or no weight bearing.
A 3 month follow-up by phone will be realized by the Investigation Clinical Center in Grenoble. Data about risk factors of thromboembolic diseases, anticoagulant therapy, medical history, new event since inclusion (hospitalization, surgery, lower limb trauma or thromboembolic events) will be collected.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1627
- patients seen during a consultation with a physician of mountain
- lower limb trauma seen within 48 hours
- patient resident in France
- conditions requiring an immediate hospitalization
- prisoners
- pregnant, nursing or parturient woman
- refused participation in follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method impact of a thromboembolic disease and heparin's complications 3 months Evaluation of the impact of a thromboembolic disease and heparin's complications in outpatients with a lower limb trauma are supported by physicians in winter sports resort. The patients will be contacted by phone 3 months after trauma to collect these data.
- Secondary Outcome Measures
Name Time Method Description of the included patients evaluation during inclusion visit epidemiological description of included patients (age, sex, travel time...)
Epidemiological characteristics of patients with a thromboembolic event or an adverse effect of the treatment 3 months compliance with the algorithm for prescribing heparin and consequences on the primary endpoint 3 months The primary endpoint consists to check the impact of thromboembolic disease and adverse effects of anticoagulant therapy at 3 month.
We compare the link between these consequences and the compliance with the algorithm about the indication of LMWH therapy.incidence of thromboembolic diseases and heparin complications in different subgroups 3 months Analysis of subgroups depending on the trauma type, the type of immobilization or not, risk factors of thromboembolic diseases, rolling step and weight bearing.
Trial Locations
- Locations (23)
Medical center "le pas du lac"
π«π·Avoriaz, France
medical center "Le chevreuil"
π«π·Autrans, France
Medical center "les Soldanelles"
π«π·Bellevaux, France
Medical center "le serre d'aigle"
π«π·Chantemerle, France
Medical center of flumet
π«π·Flumet, France
Medical home
π«π·Flaine, France
Medical center of Combloux
π«π·Combloux, France
Medical Center Brousse
π«π·Font Romeu, France
Medical center of Beauregard - "les cyclamens"
π«π·La Clusaz, France
Medical group "le YΓ©ti"
π«π·La Clusaz, France
Medical center
π«π·Villard de Lans, France
Medical group of Peric
π«π·Les Angles, France
Medical group "SELARL Sports mΓ©decine montagne"
π«π·Le Grand Bornand, France
Medical center of "Aiguille rouge"
π«π·Les Arcs, France
Medical center "Val Montjoie"
π«π·Les Contamines, France
SCP medical "le Bennevy"
π«π·Les Gets, France
Medical center of Jaillet
π«π·MegΓ¨ve, France
Medical center of Peisey-Vallandry
π«π·Peisey Vallandry, France
Resort of Peyragudes
π«π·Peyragudes, France
Medical center "Fleur des alpes"
π«π·Saint Gervais Les Bains, France
Medical center "le rocher de l'aigle"
π«π·St FranΓ§ois Longchamp, France
Medical center "medival"
π«π·Val d'isΓ¨re, France
Medical center of Valberg
π«π·Valberg Guillaumes, France